BLNST study materials
BLNST study resources

Codeine After Perineal Repair: A Sleepy 6-Day-Old

BLNST · Put your knowledge to work in context.

All case studies

Codeine After Perineal Repair: A Sleepy 6-Day-Old

A 6-day-postpartum mother had a second-degree perineal tear and was prescribed acetaminophen 500 mg/codeine 30 mg, two tablets every 6 hours, for pain. She has taken this for 3 days. Her infant, born at 3.20 kg, now weighs 3.00 kg (6.3% loss). The baby feeds about 8 times in 24 hours but is increasingly sleepy, latches briefly, and has had only 4 wet diapers today. The mother reports that the baby “won't wake enough to finish feeds.” She has no fever or breast pain and her milk appears to have transitioned. She asks whether the codeine is safe to continue because it is the only thing controlling her perineal pain. The clinic has infant scales, a lactation consultant, and access to the on-call pediatrician.

1. Assess the risk of the codeine exposure. What mechanism and infant findings drive your concern?

Read the worked answer

This is a concerning exposure, not a routine analgesia question. Codeine is a prodrug converted by CYP2D6 to morphine. Ultrarapid metabolizers convert more codeine to morphine, and morphine enters breast milk. A newborn has immature clearance, so repeated exposure can cause sedation, poor feeding, and respiratory depression. The dose here is high: two tablets every 6 hours provides 60 mg of codeine per dose, or 240 mg per day, for 3 days.

The infant's increasing sleepiness, brief latch, and only 4 wet diapers are red flags for opioid effect and inadequate intake. A 6.3% weight loss is not severe by itself, but the trend and feeding behavior matter. Risk is higher in newborns and with prolonged or high-dose exposure. Codeine is not recommended during breastfeeding, especially with a newborn, because genetic variability makes a safe dose unpredictable.

2. What immediate management would you recommend for the infant and the mother's analgesia?

Read the worked answer

Stop codeine now. Assess the infant today: alertness, respiratory rate, tone, feeding, urine output, weight, and oxygen saturation if available. The on-call pediatrician should review the infant. If there is respiratory depression, unresponsiveness, or inability to feed, send for emergency care. Otherwise, monitor closely for 24–48 hours and encourage frequent feeding; if the infant is too sleepy, the mother should express milk and feed by cup or syringe.

For maternal pain, switch to scheduled acetaminophen and ibuprofen, which are compatible with breastfeeding, plus stool softeners and nonpharmacologic measures. Avoid tramadol as well because of similar opioid risk. Do not resume codeine. If pain is uncontrolled, arrange obstetric review rather than adding another unsafe opioid.

Document the exposure, infant findings, counseling, and pediatric review. Report the suspected adverse drug reaction through the appropriate local system.

3. What counseling and follow-up would you provide, including future analgesia and documentation?

Read the worked answer

Explain that codeine is unsafe during breastfeeding because the mother's genetic ability to convert it to morphine is unknown and the infant is already showing possible opioid effects. She should not take another dose and should not use leftover codeine or tramadol. Reassure her that stopping the drug and monitoring the infant is the priority.

For future pain, recommend acetaminophen and ibuprofen at appropriate doses, hydration, stool softeners, and rest. If an opioid is ever considered, it should be a short course at the lowest effective dose with infant monitoring, and codeine and tramadol should be avoided. Follow up by phone in 24 hours and in clinic within 2–3 days. Document the infant's weight, wet diapers, alertness, respiratory status, and the counseling given. Coordinate with the pediatrician and obstetric clinician so the mother receives consistent advice.